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2Abstract
Radiotherapy is a commonly used treatment for cancer and is usually given in varying doses. At low
radiation doses relatively few cells die as a direct response to radiation but secondary radiation effects
such as DNA mutation or bystander effects affect many cells. Consequently it is at low radiation levels
where an understanding of bystander effects is essential in designing novel therapies with superior clinical
outcomes. In this article, we use a hybrid multiscale mathematical model to study the direct effects
of radiation as well as radiation-induced bystander effects on both tumour cells and normal cells. We
show that bystander responses play a major role in mediating radiation damage to cells at low-doses of
radiotherapy, doing more damage than that due to direct radiation. The survival curves derived from our
computational simulations showed an area of hyper-radiosensitivity at low-doses that are not obtained
using a traditional radiobiological model.
Introduction
Radiotherapy is used in the treatment of 50% of patients with cancer. The classic view of the action of
ionising radiation is that it inactivates cells by causing the DNA damage which leads to cell death [1].
However, depending upon circumstances, a greater or lesser proportion of the DNA damage may be
repaired, and so the consequences, at the level of the individual cell, can vary from damage with complete
repair, through damage with incomplete or inaccurate repair, to lethal damage [2]. Cells vary in their
intrinsic radiosensitivity [3] and other factors also influence the cellular response to radiation: the oxygen
level in the environment; the phase of the cell cycle; the repair capacity of individual cells. At the tissue
level, the response will depend not just upon these cellular factors, but also on the ability of the cells that
are critical for maintenance to repopulate the organ or tissue. The doses and fractionation schemes used
in clinical radiotherapy represent a compromise between the desire to eliminate as many cancer cells as
possible and the need to minimise the damage to normal cells and tissues.
Advances in molecular biology have expanded this classical view and it is now realised that signals
produced by irradiated cells can influence the behaviour of non-irradiated cells - a range of phenomena
known as the “bystander effect” [2, 4–7]. New technologies such as intensity-modulated radiotherapy
(IMRT) allow irregularly shaped target volumes to be irradiated to high-dose whilst minimising the dose
to vulnerable normal structures immediately adjacent to the tumour. The penalty paid however is an
increase in the volume of normal tissue that is treated to a low-dose of radiotherapy [8]. Since direct
cell-kill is relatively low at low-radiation doses, bystander effects play a major role in determining the fate
of cells and may be particularly relevant to radiation-induced carcinogenesis. Therefore, it is important
to understand how novel therapeutic techniques might influence the occurrence and clinical consequences
of bystander effects [13,17]. This is not an easy problem to investigate: it may be years before the
consequences are expressed; the bystander effects may be swamped by effects on directly irradiated
cells; the mediators and targets for bystander effects are poorly understood [2, 9]. Mathematical and
computational models offer the potential, at least in part, to circumvent these difficulties. By providing
mechanistic insights into bystander phenomena these approaches will help to identify the key factors
that are involved. Traditionally the linear quadratic model has been used as a useful tool for assessing
radiotherapeutic treatments [10–13]. Furthermore, several mathematical models have been proposed to
incorporate and study the effects of bystander phenomena [14–20]. Since the effects of radiation on
tissue can manifest themselves in many ways at the cell, tissue and organ levels, we need systems-based
multiscale model to better understand the impact of bystander signals on clinical outcomes. Multiscale
approaches have the ability to incorporate several critical interactions that occur on different spatio-
temporal scales to study how they affect a particular cell’s radiation sensitivity, whilst simultaneously
analysing the effects of radiation at the larger (tissue) scale [12,20,21].
In this article, we develop the hybrid multiscale mathematical and computational model to study
3multiple effects of radiation and radiation-induced bystander effects on a growing tumour within host
tissue. We use the new multiscale model to predict the effects of bystander signals on tissue treated with
different radiation dosage protocols and analyse its implications for radiation protection, radiotherapy
and diagnostic radiology.
Materials and Methods
The multiscale mathematical model is developed by incorporating intracellular cell-cycle dynamics, an ex-
ternal oxygen concentration field and various effects of irradiation, including radiation-induced bystander
effects that occur at multiple spatial and temporal scales. A comprehensive overview of the multiscale
model with equations and parameter values can be found in previous papers by Powathil et al. [12,22,23]
and in the Supplementary Materials. Here, we investigate the effects of varying doses of ionising radiation
on single cells and how this affects their non-irradiated neighbours (“bystander phenomena”). We use a
hybrid multi-scale modelling approach to simulate the growth and progression of the tumour cells incor-
porating intracellular cell-cycle dynamics and microenvironmental changes in oxygenation status [12,22].
The intracellular cell-cycle dynamics are modelled using a set of five ordinary differential equations that
govern the dynamics of key proteins involved in cell-cycle regulation [12,24,25]. The changes in the oxygen
concentration within the domain of interest are incorporated into the model using a partial differential
equation, governing its production, supply and diffusion [11,12]. The details of these can be found in the
Supplementary Materials as well as previous articles by Powathil et al. [12, 22].
The simulations start with a single initial tumour cell in G1-phase of the cell-cycle at the center
of a host normal tissue. Repeated divisions of the tumour cells - governed by the system of ordinary
differential equations (ODEs) modelling the cell-cycle dynamics produce a cluster of tumour cells. We
have assumed that the normal cells divide only when there is free space in the neighbourhood (following
the ODEs modelling the cell-cycle dynamics but with longer cell-cycle time), thus avoiding uncontrolled
growth. Following the Cellular Potts Model methodology [26] we measure time in units of Monte Carlo
Steps (MCS). In our model a single MCS corresponds to 1 hour of real time. The diffusion constants
for oxygen and bystander signals are 2.5 × 10−5 cm2s−1 [22] and 2 × 10−6 cm2s−1 [27, 28]. We used an
explicit Forward Euler numerical integration method to solve the PDEs governing oxygen and bystander
signal dynamics. To avoid numerical instabilities we used a smaller time step in the numerical solutions
of the PDE which required multiple calls to diffusion subroutine in each MCS (1000 for oxygen and 100
for bystander signals). Here, the decay rate of the radiation signal is assumed to be ηs = 0.021 m
−1 [28]
and the rate of production of the bystander signal is assumed to be dose-independent free parameter,
normalised to 1 within the nondimentionalised equation. The parameters representing the decay and
the production rates may vary over a very wide biologically plausible range, depending on the molecular
nature of the signal, cell type and extracellular environment. Although some of the in vitro data suggest
an infinite propagation of signals, measurements of bystander effect propagation in three-dimensional
tissue-like systems [29] and in vivo studies involving partial-body irradiation of mice [30] show a finite
range [19]. This large variability suggests that these parameters together with the bystander response
threshold and the probabilities (Figure 2) can be further adjusted to study and reproduce various data
sets, depending on the information on several factors such as molecular nature of the signal, cell type
and extracellular environment.
At each step, all the cells are checked for the concentrations of intracellular protein levels and their
phases are updated. If [CycB] is greater than a specific threshold (0.1) a cell is considered to be in G2
phase and if it is lower than this value, a cell is in G1 phase [12,24,25]. If the [CycB] crosses this threshold
from above, the cell undergoes cell division and divides (along randomly chosen cleavage plane). As the
cells proliferate, the oxygen demand increases and in some regions, the concentration of oxygen falls
below a threshold value (10% of oxygen), making the cells hypoxic. Hypoxic cells are further assumed to
have a longer cell-cycle due to the cell-cycle inhibitory effect of p21 or p27 genes expressed through the
4activation of HIF-1 under hypoxia [31–33](incorporated into Eq (1) of ODE system in Supplementary
Materials). Furthermore, if the oxygen level of a cell falls below 1%, that cell is assumed to enter a resting
phase with no active cell-cycle dynamics [32].
To study the radiation effects, and to compare the direct and indirect effects of radiation, cells are
assumed to be exposed to varying doses of radiation for 5 days, once a day starting from time=500 hr. The
radiation is considered to affect the targeted cells either by direct effects through the direct induction of
DNA double-strand breaks or by indirect effects through the radiation-induced bystander effects [2,5–7].
Figure 1 illustrates various radiobiological effects of cell irradiation with the light green area indicating
the direct effects and grey area showing the territory of the bystander effects. The direct effects of
irradiation are modelled using a modified cell-based linear quadratic model, incorporating the effects
of varying cell-cycle and oxygen dependent radiation sensitivities and other intracellular responses [12].
The survival probability of a cell after radiation is traditionally calculated using a linear quadratic (LQ)
model [34]. Following Powathil et al. [12], the modified linear quadratic model to study a cell’s response
to the irradiation is given by:
S(d) = exp
[
γ
(−α.OMF.d− β(OMF.d)2)] . (1)
The parameter γ accounts for the varying sensitivity due to the changes in cell-cycle phase and varies
from 0 to 1, depending on a cell’s position in its cell-cycle phase. As studies indicate, G2 /M phase cells
are assumed to show maximum sensitivity (1) to radiation, while cells in G1 phase and resting cells are
assumed to have a relative sensitivity of 0.75 and 0.25 respectively. We further assumed that normal cells
that are not in the proliferative phase are less responsive to the radiation with a sensitivity of 0.25. The
parameters α and β are called sensitivity parameters and are cell/tissue specific while d represents the
radiation dosage. The effects of varying oxygen levels on a cell’s radiation response is incorporated into
the modified LQ model using the oxygen modification factor (OMF) parameter given by:
OMF =
OER(pO2)
OERm
=
1
OERm
OERm.pO2(x) +Km
pO2(x) +Km
(2)
where pO2(x) is the oxygen concentration at position x, OER is the ratio of the radiation doses needed
for the same cell kill under anoxic and oxic conditions, OERm = 3 is the maximum ratio and Km = 3
mm Hg is the pO2 at half the increase from 1 to OERm [12,35]. The model also assumes that after a low
dose exposure to irradiation (< 5Gy), about 50% of the DNA damage is likely to be repaired within a
few hours, increasing the survival chances of the cells and hence the final survival probability is written
as:
S∗(d) =
 S d > 5
S + (1− S)× 0.5 d ≤ 5.
(3)
Furthermore, in calculating the radio-responsiveness of the irradiated cells, we have considered the effects
of dynamic changes in radiosensitivity occurring post-exposure due to the redistribution of cells within
the cell-cycle, repopulation of the tumour cell mass, reoxygenation of the tumour, and DNA repair delay
in calculating the radio responsiveness of the irradiated cells. A detailed description can be found in
Powathil et al. [12] and Supplementary Materials.
Experimental evidence shows that in addition to the direct damage due to radiation, irradiated cells
produce distress signals, to which all neighbouring cells (i.e. both irradiated and non-irradiated) respond
[2]. One of the in vitro studies has shown that these signals produced by the irradiated cells reach a
maximum after 30 minutes of radiation and remain steady for at least 6 hours after the radiation [36].
They have also showed that the signals could be transferred anywhere within the experimental dish [36].
The indirect radiation bystander effects are produced by these radiation-induced signals sent by the
5irradiated cells that are directly exposed to the radiation [2]. To model the effects of radiation damage to
individual cells and to account for bystander effects we consider a field of bystander signal concentration
(Bs(x, t)) which by diffusing to nearby cells produces probabilistic responses to these bystander signals
i.e. the single bystander signal concentration field serves as a proxy for the multiple real bystander signals
that affect cells adjacent to radiated regions in real, live tissue. Motivated by the experimental results,
we assume that the spatio-temporal evolution of the signals is modelled by a reaction-diffusion equation,
incorporating the production and decay of the signals from the irradiated cells, given by:
∂Bs(x, t)
∂t
= Ds∇2Bs(x, t)︸ ︷︷ ︸
Diffusion
+ rscellRad(Ω, t)︸ ︷︷ ︸
Production
− ηsBs(x, t)︸ ︷︷ ︸
Decay
(4)
where Bs(x, t) denotes the strength or concentration of the signal at position x and at time t, Ds is the
diffusion coefficient of the signal (which is assumed to be constant), rs is the rate at which the signal
is produced by an irradiated cell, cellRad(Ω, t) (cellRad(Ω, t) = 1 if position x ∈ Ω is occupied by a
signal-producing irradiated cell at time t and zero otherwise) and ηs is the decay rate of the signal. The
bystander cells will then respond to these signals in multiple ways with various probabilities when the
signal concentration is higher than a certain assumed threshold. To study the radiation-induced damage
to both tumour cells and normal cells, we have assumed that the tumour cells grow within a normal cell
population.
The multiple biological responses of the responding neighbouring cells include cell death, mutation
induction, genomic instability, DNA damage and repair delay [1, 2, 4]. These biological effects are il-
lustrated in the Figure 1. Figure 2 shows the schematic diagram of the various biological responses of
radiation that are incorporated into the computational model. It is assumed that all cells that undergo
cell-death due to the direct effect (calculated based on LQ survival probability) emit these signals while
the surviving irradiated cells that are under repair delay produce these bystander signals with some prob-
abilities (Pts = 0.5 and Pns = 0.2 with Pts > Pns in Figure 2). It has been observed experimentally
that not all cells respond to radiation-induced bystander signals and in addition, tumour cells are much
more sensitive to bystander signals than normal cells are [1, 37]. Hence, we assume that the tumour
cells respond to the bystander signals with a higher probability than that of normal cells (Ptb = 0.3 and
Pnb = 0.2 with Ptb > Pnb). The cells that respond to these radiation-induced bystander signals react
in various ways as illustrated in Figure 1 and we consider some of these bystander responses within the
multiscale model as shown in Figure 2. Depending on the signal concentration, these responses can be
either protective or damaging [1, 19]. Here, these threshold intensities are taken to be Kn1 = Kt1 = 3
and Kn2 = Kt2 = 4 (signal concentration is normalised with production rate), as shown in Figure 3.B,
assuming that cells require a higher intensity threshold to respond to the bystander signals and there is
a continuous response at least until 6 hours [36]. However, depending on the cell line specific data, one
could increased or decrease this threshold accordingly.
Protective responses involve delay to repair the DNA damage caused by the signals; damaging re-
sponses involve radiation-induced bystander cell-kill and mutagenesis. Normal cells that are responding
to the bystander signals are assumed to undergo repair delay for upto 6 hours if the concentration of
bystander signal is higher than a threshold (Kn1 < Bs(x, t) < Kn2 with Kn1 = 3 and Kn2 > 4) [36].
If the concentration is greater than this threshold (Bs(x, t) > Kn2) then with a series of probabilities
the cell will undergo bystander signal induced cell death (if random probability is less than Pnk = 0.1)
or will mutate and initiate a radiation-induced cancer (if random probability is greater than Pnk = 0.1).
Similarly, tumour cells responding to the bystander signals either undergo bystander signal induced cell
death (Bs(x, t) > Kt2) or repair delay (Kt1 < Bs(x, t) < Kt2 with Kt1 = 3 and Kt2 > 4) depending
on the signal concentration [1, 2]. As Mothersill and Seymour [38] indicated, it is hard to determine the
exact probabilities or thresholds by which these bystander responses of normal or tumour cells occur but
we provide a sensitivity analysis of these probabilities on the cell-kill in the Supplementary Materials. A
6comprehensive list of rest of the parameters used in the model can be also found in the Supplementary
Materials.
Results
The clinical advantage of radiation therapy critically dependent on a compromise between the benefit
due to the radiation-induced tumour cell-kill and the potential damage to normal tissues [9]. In addition
to the direct cell-kill, radiation can also cause multiple biological effects that are not directly related
to the ionising events caused due to the irradiated dosage. Figure 1 illustrates various radiobiological
effects of cell irradiation with the light green area indicating the direct effects and grey area showing the
territory of the bystander effects and Figure 2 shows the relevant effects that are included in the present
hybrid multiscale model. Firstly, we simulate a growing tumour within a cluster of normal cells using
the multiscale mathematical model that is described in the methodology section. Figure 3.A shows the
spatio-temporal evolution of the host-tumour system at times=100, 300, 500 and 700 hrs. The colours of
each cell represent their specific position in their cell-cycle and the hypoxic condition, as illustrated in the
figure legend. The figure also shows the changing morphology of the growing tumour and the development
of fingerlike projections at the tumour boundary as seen in most of the human malignancies. This also
indicates that the host-tumour interaction can play a major role in spatial distribution and development
of a growing tumour through competitive interactions [39].
To study the effects of radiation, we consider three types of radiation delivery and exposure to treat
a growing tumour within a cluster of normal cells. In most of the cases of current radiation delivery
planning, the dosage received by both tumour volume and surrounding normal volume is not uniform.
While the gross tumour volume (GTV) and clinical target volume (CTV) receive high dose radiation, rest
of the surrounding area, the irradiated volume receive a decreasing dosage depending on their distance
from the GTV or CTV. In case 1, we consider that a tumour is treated homogeneously to the prescribed
dose per fraction and the rest of the irradiated normal tissue receives lower doses with decreasing intensity
depending on their location from the tumour rim, as would occur in the clinical context. Case 2 analyses
the radiation effects assuming that only tumour cells are fully exposed to the given radiation dose, sparing
any normal cells which is an ideal scenario for radiation planning and in case 3, we consider the worst
case scenario where both tumour and surrounding normal cells receive the same given dosage. In the
following, we will discuss the results of these three cases and their clinical implications.
In Figure 3.B, we plot the spatio-temporal evolution of the host-tumour system before and after one
of the five doses of irradiation at time=548 hr. Plots in the upper row of the Figure 3.B show the
spatial distribution of cancer and normal cells with bystander signal producing cells labelled in light blue.
These plots show that after the irradiation, most of the signalling cells are located at the area exposed
to relatively lower doses of radiation (time=552 hr) as higher doses of irradiation leads to direct cell-kill.
The plots also show that the radiation-induced cell-death creates empty spaces, reactivating the growth
or normal cells in the neighbourhood (yellow and purple cells). The plots in the lower panel of Figure 3.B
show the change in the concentrations of radiation-induced bystander signals emitted by the cells that are
labelled in light blue. The scaled values shown in the colormap indicate the strength of these bystander
signals with maximum value 3. The signal concentrations beyond this value trigger bystander responses
from either normal or tumour cells. The plots show that at time=546 hr, there are bystander signals
of lower strength than those previously produced by signalling cells during the fraction at time=524
hr. Although the strength of these signals represented here are weak at time=548 hr, depending on the
number of signalling cells and irradiation fractions, this could build up over a number of radiation fractions
to reach a damaging level that might trigger bystander responses. After the irradiation at time=548 hr,
the concentration of bystander signals increase and stay above the threshold value for around 6-10 hours,
before dropping below the threshold as it is observed in the experimental studies [36]. Moreover, there is
a dynamically changing, heterogeneous concentration of bystander signals throughout the host-tumour
7system. The simplified use of threshold value could be justified by the experimental observation [36] that
the radiation-induced bystander effects are a distance-dependent phenomenon and that the responses in
cells close to the signalling cells are significantly greater than those in more distant cells.
The direct and indirect effects of radiation when the host-tumour system is treated with specific
doses of radiation for the three cases described above are shown in Figure 4. The figure shows the total
cell-kill due to the radiation and the contributions from the direct hit and other bystander responses
for various dose per fractions. The plots show that, in all three cases, the total cell-kill increases with
an increase in the dose per fraction. However, at the lower doses (dose = 0.25 Gy and dose = 0.5
Gy) the contributions from the radiation-induced bystander cell-kill predominate - as seen in previous
experimental studies [2, 36]. Moreover, as opposed to the direct cell-kill calculated using LQ model, the
bystander responses are similar even with an increase in the radiation dosage. In case 1 (Figure 4. A), the
surrounding normal cells that are exposed to a decreasing intensity of radiation dosage also respond to
the radiation-induced bystander signals with bystander signal induced cell-kill or increased DNA damage
contributing to carcinogenesis. However, in case 2 (Figure 4. B), the radiation-induced bystander effects
are minimal and does not, contrary to case 1, induce any mutation. The data from Figure 4. C for
the case 3 shows that there is a significant increase in the radiation-induced direct cell-kill, although the
bystander cell-death is similar to that in the previous scenarios. The plots also show that the irradiation
of normal cells may also lead to DNA mutation, increasing the chances of carcinogenesis.
Figure 5 shows the survival fractions of the host-tumour system for all three cases when it is treated
with 5 fractions of radiation with varying doses and is further qualitatively compared to experimental
results by [40]. The survival fractions of the system are compared with and without the bystander signal
induced cell-kill, assuming that the total number of cells for the control case is 1000. The plots show a
region on high cell-kill at the doses 0.25 Gy and 0.5 Gy (the tumour is exposed to the maximum dose
while normal cells receive less than the maximum dose) as compared with doses greater than 0.5 Gy. The
region of hyper radio-sensitivity at low dose levels or inverse-dose effect, as seen in the Figures 5.A- 5.C is
also observed in several experimental studies, as shown in Figure 5.D [1,40,41] and is not predicted using
the traditional LQ models. The survival curves for case 3 are plotted in Figure 5.B which compared with
the previous cases, shows less pronounced hyper radio-sensitivity. This is due to the increase in direct
cell-kill of both normal and tumour cells since all the cells are exposed to the given maximum dosage.
Additional results showing the multiple factors involved in the direct and indirect effects of radiation are
given in Supplementary Materials.
Discussions
Radiation-induced bystander effects have shown to play a major role in determining the overall effects
of radiation, especially at low dose rates [1, 2, 4, 9]. Although, the precise mechanisms underlying the
induction and response of bystander signals are not yet fully understood, several molecular and intracel-
lular cell communication processes have been widely implicated in mediating bystander effects [1, 2, 5].
The cells that are in direct contact with each other are thought to support bystander signalling through
the gap junctions [2]. The bystander responses of the cells that are not in close contact are mediated
through the release of diffusive protein-like molecules such as cytokines from the cells that are irradi-
ated. Although, radiation-induced bystander effects have been extensively studied experimentally, their
relevance and role in clinical radiation treatment and human carcinogenesis risk remain to be explored
further [9, 42]. Most of the experimental studies investigating the bystander responses are based on in
vitro systems where cells are grown within media and showed no significant spatial effects as signals seem
to diffuse rapidly throughout the medium [36, 43]. However, spatial heterogeneity has been observed in
more tissue like structures [29] and hence consideration of spatial variation is important while studying the
bystander effects in clinically relevant systems. The complex nature of various radiobiological interactions
within a living organism after radiation exposure further limits detailed in vivo and clinical investiga-
8tions [4,9]. Nevertheless, our continued pursuit of bystander experimental studies using more complex in
vitro and tissue models, highlights the importance of identifying key processes and parameters that may
play vital role in radiation-induced bystander responses. Here, we have presented a mathematical and
computational modelling approach to study the direct and indirect effects of radiation and in particular,
radiation-induced bystander effects, after exposing the host-tumour system to varying radiation doses.
We considered the computational analysis of a growing tumour within a cluster of normal cells, in-
corporating those properties of individual cells (cell-cycle phase; external oxygen concentration) that
influence the direct and indirect responses of cells to irradiation. The direct effects of radiation were
studied using a modified linear quadratic model that incorporates some of the important factors respon-
sible for radiation sensitivity such as cell-cycle phase-specific radiation sensitivity, improved survival due
to DNA repair, and hypoxia. We have also considered the indirect effects of radiation though bystander
effects, where the assumption is that irradiated cells produce bystander signals as a result of stress due
to DNA damage. These signals diffuse within and around the irradiated volume. Computations in-
volving bystander effects were carried out using probabilistic methods, assigning specific probabilities
for the production of bystander signals and responses towards bystander signal concentration. The rest
of the parameters in the model were either chosen from literature or extracted from experimental ob-
servations [12, 23, 36]. Here, we do not focus on explicitly fitting our model results to any particular
experimental data which vary depending on multiple factors such as the nature of the experiment (in
vivo or in vitro studies), the cell type or the molecular nature of the cell, but rather try to understand
experimental observations and qualitatively study the effects of bystander effects on overall radiation
effectiveness and responses. However, with the help of a relevant data set, if desired, our current model
can be further tuned to reproduce various experimental results.
The computational models were then used to study the radiobiological effects of radiation considering
three different total treatment volume and varying radiation doses per fraction. The results obtained from
the model are qualitatively in good agreement with the experimental findings and clinical observations.
In all three cases, the cell-kill due to the bystander effects dominated the total radiation cell-kill at
low dose rates when the majority of the cells are exposed to low dose radiation, while the proportion
of direct cell-kill increased with the increase in the radiation dosage (Figure 4). However, the cell-kill
due to the bystander effects remained relatively similar, irrespective of the varying doses per fraction.
These findings are qualitatively in good agreement with the experimental findings by Hu et al. [36],
who irradiated fibroblasts to study the spatio-temporal effects of bystander responses by calculating the
fraction of DNA double strand breaks (DSBs). They found that within the irradiated area, the fraction
of DSBs was high with higher doses (direct cell-kill) but the region outside the irradiated volume had
lower but relatively similar rates of DSBs regardless of the dosage level (bystander effects). They also
found that at lower dosage level, the fraction of bystander induced DSBs is almost equal to the fraction
of DSBs (both bystander and radiation-induced) within the irradiated volume (Figure 3 in [36]).
Figure 4 also shows the bystander responses of surrounding normal cells. Comparing cases 1, 2
and 3, it can be seen that when the both normal and tumour cells are exposed to the irradiation,
the bystander responses of normal cells include bystander signal induced cell-death and DNA mutation
potentially contributing to the carcinogenesis. However in case 2, when the total treatment volume
contains tumour cells only, no significant bystander responses are observed in normal tissue (except for
repair delay associated with the DNA damage induced by bystander signals). This is in accord with
the clinical observation that highly localised (small treatment volume) radiation is more effective than
techniques using higher volumes, although this is still a matter of some debate [44].
The survival curves plotted for all three cases (Figures 5.A-5.C) showed an inverse dose-effect: an
increase in cell-killing at a range of low dose rates that would not be predicted by back-extrapolating
the cell survival curve for high dose rates. These findings are qualitatively in consistent with the sev-
eral experimental observations that showed a region of low dose hypersensitivity [1, 40, 41]. Figure 5.D
shows once such experimental result where survival curves of asynchronous T98G human glioma cells
9irradiated with 240 kVp X-rays and measured using cell-sort protocol is plotted. In the Figure, the
area of hypersensitivity can be observed with in the dose range of 0-1 Gy. Although, some of the ex-
perimental evidence suggests that increased DNA repair might contribute increased resistance at higher
doses [40,41], the present results suggest that radiation-induced bystander responses might contribute to
this observed hypersensitivity [1]. An increased number of actively signalling cells at lower doses could
explain the dominance of bystander cell-death over radiation-induced cell death at low dose rates and
thus contributing to an inverse-dose effect.
Analysing the direct and indirect effects of radiation for all three cases, it can be seen that the volume
of exposure and the dose of radiation have major effects on total cell-kill and bystander responses. In
case 1, more normal cells are killed when the tumour cells are irradiated with doses greater than 1.5 Gy,
exposing the normal cells to doses from 0 Gy to 1.5 Gy. The greater cell-kill at higher doses reduces the
number of bystander signal producing cells, resulting in lower bystander responses at higher doses. In
short, at low dose rates, low direct cell-kill and moderate bystander cell-kill contribute to the total cell-kill
while at higher doses, high direct cell-kill of tumour cells, moderate direct cell-kill of normal cells and low
bystander cell-kill add to the total cell-kill. In case 2, the direct effects are based on the contribution from
direct tumour cell-kill. At higher doses more tumour cells are killed, reducing the number of signalling
tumour cells, while at low doses more tumour cells produce bystander signals, increasing the bystander
response and cell-kill. As compared to cases 1 and 2, the survival curve for case 3, showed a less significant
region of hypersensitivity at low doses. This is because when a uniform dose is given to the entire system,
there is high cell-death of both tumour and normal cells due to direct irradiation and at low dose rates,
all the cells are exposed to the given dose as oppose to the case 1 where they receive a range of doses from
0 to the maximum. In all three cases, the damages induced by the bystander effects on normal cells are
minimal as we assumed that the normal cells are less likely to produce bystander signals, they have high
repair capability (less direct effects) and they do not respond well to the surrounding bystander signals,
as suggested by the experimental observations [1, 37].
Our understanding of the role of radiation-induced bystander signals in mediating the risk of secondary
cancers after treatment is limited. Most of the findings about the bystander effects are derived from in
vitro studies with artificial settings and limited clinical applicability. Multiscale mathematical models such
as the one we present here can serve as powerful investigative tools, incorporating multi-layer complexities
to understand and identify the multiple parameters that are significant in radiation-induced bystander
responses. The computational model we have developed explores the spatio-temporal nature of radiation-
induced bystander effects and their implications for radiation therapy. By explicitly incorporating a
consideration of bystander effects on tumours and normal tissues, our model can be used to enrich the
information provided by traditional LQ models and thereby expand our knowledge of the biological effects
of ionising radiation.
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Figure Legends
Figure 1. Diagram showing multiple biological effects of radiation. Here, classical radiation biology
operates within the area shaded green and bystander effects operate within the area shaded grey.
Figure 2. Diagram showing various interactions that are incorporated into the computational model
when a growing tumour within normal tissue is irradiated. Here, we have added the responses of both
normal and tumour cells.
Figure 3. Plots showing the spatio-temporal evolution of host-tumour dynamics with and without
treatment. (A) Plots showing the growing tumour at four different simulation time steps and (B) Plots
show the changes in the spatial distribution when the host-tumour system is irradiated at times=548.
Upper panel shows the changes in cell distribution as well as the signalling cells after irradiation and
the lower panel shows the distribution of bystander signals with colour map indicating various threshold
values
Figure 4. Plots show the number of cells killed under the direct effects and indirect effects of radiation
and other bystander signal responses. (A) Case 1: tumour cells are exposed to full given radiation dose
while the surrounding normal cells receive gradient of doses, (B) Case 2: tumour cells are exposed to
full given radiation dose while the surrounding normal cells are spared completely and (C) Case 3:
tumour and normal cells are exposed to full given radiation dose.
Figure 5. Plots show the differences in the survival fraction when bystander responses are considered.
(A) Case 1: tumour cells are exposed to full given radiation dose while the surrounding normal cells
receive gradient of doses, (B) Case 2: tumour cells are exposed to full given radiation dose while the
surrounding normal cells are spared completely (C) Case 3: tumour and normal cells are exposed to full
given radiation dose. and (D) Experimental result: survival of asynchronous T98G human glioma cells
irradiated with 240 kVp X-rays, measured using the cell-sort protocol (Figure from Joiner et al. [40],
used with copyright permission)
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Figures
Figure 1. Diagram showing multiple biological effects of radiation. Here, classical radiation biology
operates within the area shaded green and bystander effects operate within the area shaded grey.
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Figure 2. Diagram showing various interactions that are incorporated into the computational model
when a growing tumour within normal tissue is irradiated. Here, we have added the responses of both
normal and tumour cells.
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Figure 3. Plots showing the spatio-temporal evolution of host-tumour dynamics with and without
treatment. (A) Plots showing the growing tumour at four different simulation time steps and (B) Plots
show the changes in the spatial distribution when the host-tumour system is irradiated at times=548
hr. Upper panel shows the changes in cell distribution as well as the signalling cells after irradiation
and the lower panel shows the distribution of bystander signals with colour map indicating various
threshold values
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Figure 4. Plots show the number of cells killed under the direct effects and indirect effects of radiation
and other bystander signal responses. (A) Case 1: tumour cells are exposed to full given radiation dose
while the surrounding normal cells receive gradient of doses, (B) Case 2: tumour cells are exposed to
full given radiation dose while the surrounding normal cells are spared completely and (C) Case 3:
tumour and normal cells are exposed to full given radiation dose.
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Figure 5. Plots show the differences in the survival fraction when bystander responses are considered.
(A) Case 1: tumour cells are exposed to full given radiation dose while the surrounding normal cells
receive gradient of doses, (B) Case 2: tumour cells are exposed to full given radiation dose while the
surrounding normal cells are spared completely (C) Case 3: tumour and normal cells are exposed to full
given radiation dose. and (D) Experimental result: survival of asynchronous T98G human glioma cells
irradiated with 240 kVp X-rays, measured using the cell-sort protocol (Figure from Joiner et al. [40],
used with copyright permission)
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Figure S1. Schematic diagram of the model showing the appropriate scales involved
Cell growth: The CompuCell3D framework
The computational simulations are carried out using the CompuCell3D framework developed
by Glazier et al. (see http://www.compucell3d.org for full details). To simulate the growth of
a tumour monolayer from a single cell we use a 2-dimensional lattice of size 300 × 300 pixels
in the x− and y−directions and it mainly consists of four major components. These are: (1)
cells (either tumour or normal cells) whose spatio-temporal evolution is controlled by internal
cell-cycle dynamics and the external microenvironment; (2) cross-sections of blood vessels from
where the oxygen is supplied within the domain and (3) diffusive fields - oxygen concentration
distribution and radiation-induced bystander signals.The initial configuration is one single cancer
cell surrounded by a cluster of normal cells and a number of blood vessels. Division of the cells
and hence growth of the tumour mass is driven by internal cell-cycle dynamics, modelled using a
set of ordinary differential equations. These are incorporated into the Compucell3D framework at
each Monte Carlo time step (MCS) of the simulation using Bionetsolver. Bionetsolver is a C++
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2library that permits easy definition of sophisticated models coupling reaction-kinetic equations
described in SBML with the defined cells for execution in CompuCell3D [1, 2]. Bionetsolver
makes use of the SBML ODE Solver Library to implement reaction-kinetic network dynamics
which can regulate the cell-cycle dynamics for each cell within the domain. The oxygen and drug
concentrations are incorporated into the CompuCell3D as diffusive chemical fields modelled by
PDEs governing the spatio-temporal dynamics. Regarding the time-scale of tumour growth,
each MCS is assumed to be one hour in length and the parameters in the multiscale model are
scaled accordingly. A schematic diagram of the model showing various scales involved is given
in the Figure S1
Cell-cycle dynamics and intracellular heterogeneity
Following Powathil et al. [2–4], the growth and division of cells within this hybrid multiscale
model is modelled using a system of ODEs that describes the changes in the concentrations of
some of the key proteins that are involved in the cell-cycle mechanism. Here, we use a basic cell-
cycle model adapted from Tyson and co-authors [5,6]. Using the kinetic relations they explained
the transitions between two main states, G1 and S-G2-M, of the cell-cycle, which is (in their
model) controlled by changes in cell mass. Here, the transition between phases is constrained by
the cell’s volume that increases after each MCS. The system of ODEs governing the cell-cycle
dynamics is given by:
d[CycB]
dt
= k1 − (k′2 + k
′′
2 [Cdh1] + [p27/p21][HIF ])[CycB], (1)
d[Cdh1]
dt
=
(k
′
3 + k
′′
3 [p55cdcA])(1− [Cdh1])
J3 + 1− [Cdh1] −
k4[volume][CycB][Cdh1]
J4 + [Cdh1]
, (2)
d [p55cdcT]
dt
= k
′
5 + k
′′
5
([CycB][volume])n
Jn5 + ([CycB][volume])
n
− k6 [p55cdcT], (3)
d [p55cdcA]
dt
=
k7[Plk1]( [p55cdcT]− [p55cdcA])
J7 + [p55cdcT]− [p55cdcA]
− k8[Mad] [p55cdcA]
J8 + [p55cdcA]
− k6 [p55cdcA], (4)
d[Plk1]
dt
= k9[volume][CycB](1-[Plk1])− k10[Plk1], (5)
where ki are the rate constants, the values being chosen in proportional to those in Tyson and
Novak [5, 6] as given in Powathl et al. [3]. The rate constants are scaled in such a way that it
gives an average cell-cycle length of 20-25 hours under normal conditions. The parameter values
of the cell-cycle model are scaled in such a way that each MCS step corresponds to 1 hour in
real time and a normal cell has an average cell-cycle length of 25-35 hours while a cancer cells
proliferate twice as faster. For simulations involving tumour growth, the GGH target volume is
incremented each MCS during the growth phases at a constant rate of 0.5 times the current cell
volume. The cell-cycle model is incorporated into the CompuCell3D framework at each MCS
using Bionetsolver and the SMBL ODE solver library.
3The tumour microenvironement
Overall tumour progression and cell-cycle dynamics are critically dependent on the surrounding
tissue microenvironment and in particular, the availability of oxygen. Here, the temporal and
spatial evolution of the oxygen concentration distribution is modelled using the following partial
differential equation [3] and is incorporated into the CompuCell3D framework as a diffusive
chemical field:
∂K(x, t)
∂t
= ∇.(DK(x)∇K(x, t)) + r(x)m(Ω)− φK(x, t)cell(Ω, t) (6)
where K(x, t) denotes the oxygen concentration at (pixel) position x at time t, DK(x) is the
diffusion coefficient and φ is the average rate of oxygen consumption by a cell with an area (in
2 dimensions) Ω at time t (cell(Ω, t) = 1 if position x ∈ Ω is occupied by a cell at time t and
zero otherwise). Here, m(Ω) denotes the vessel cross section with an area Ω (m(Ω) = 1 for
the presence of blood vessel at position x ∈ Ω, and zero otherwise); thus the term r(x)m(Ω)
describes the production of oxygen at an average rate r(x) (averaged over the vessel cross
section area). This equation is solved using no-flux boundary conditions and an appropriate
initial condition [7]. We have used the same parameters values as Powathil et al. [3] and for the
consistency we simulated the diffusion equation for the oxygen 1000 times in every 1 MCS to
achieve the similar time scale of 0.001 hr [3]. We assume that hypoxia up-regulates the HIF 1
(Hypoxia Inducible Factors) pathway, which further results in changes in intracellular cell-cycle
dynamics. When the average oxygen concentration at a specific cell location Ω falls below 10%
(hypoxic cell), HIF-1 α is assumed to become active from an inactive phase, which further delays
the cell-cycle dynamics (cf. Equation (1)).
Radiation response
Following Powathil et al. [4], the direct effects of radiation is incorporated into the multiscale
model using the survival probability after the irradiation, given by:
S(d) = exp
[
γ
(−α.OMF.d− β(OMF.d)2)] . (7)
where d is the radiation dose and α and β are sensitivity parameters, taken to be α = 0.3 Gy−1
and β = 0.03 Gy−2 [7]. The effect of changing tissue oxygen levels on the radiation sensitivity is
incorporated by using the concepts of an “oxygen enhancement ratio” or “oxygen modification
factor” [7], defined as
OMF =
OER(pO2)
OERm
=
1
OERm
OERm.pO2(x) +Km
pO2(x) +Km
(8)
where pO2(x) is the oxygen concentration at position x, OER is the ratio of the radiation doses
needed for the same cell kill under anoxic and oxic conditions, OERm = 3 is the maximum
ratio and Km = 3 mm Hg is the pO2 at half the increase from 1 to OERm [7, 8]. We have
incorporated cell-cycle dependent varying sensitivity by an additional term γ and it varies from
40 to 1, depending on the individual cell’s position at the time of the irradiation. Here, we
assumed that the cells in S-G2-M phase has maximum sensitivity with γ = 1 while the cells in
G1 phase and the resting phase has relative sensitivities of γ = 0.5 and γ = 0.25, respectively.
We also accommodate cellular repair after the low-doses of irradiation and assume about 50%
of the DNA damages are likely to be repaired within few hours, increasing the survival chances
of the cells and hence the final survival probability is written as:
S∗(d) =

S d > 5
S + (1− S)× 0.5 d ≤ 5.
(9)
This survival probability is then used to calculate the survival chances of each cell when
they are irradiated with the radiation rays. To study this survival chance of an individual cell,
a random number is drawn for each cell at every time when they are irradiated and compared
against the calculated survival probability. The irradiated cell survives if the random number is
smaller than the survival probability and die otherwise.
Here, we also consider the effects of radiation on cell-cycle as irradiation results in a divisional
delay, and, in particular, G2 phase delay/arrest in many cell lines [9, 10]. Experimental results
show that irradiated cells in G2 phase may take up to 9 hours longer to complete the cell-cycle
due to the activation of several intracellular repair mechanisms induced by the radiation [10].
Radiation damage can also induce a cell-cycle delay in G1 phase, mainly through the activation
of p53 and p21 pathways [9]. In the present model, we include this effect of irradiation induced
delay by forcing the cells to stay in the same phase for an extra time duration of up to 9
hours [10].
The indirect effects of radiation exposure is assumed to occur through the productions of
radiation-induced bystander signals to which surviving irradiated cells and non-irradiated cells
respond. The spatio-temporal evolution of these bystander signals are modelled using a reaction-
diffusion equation, given by
∂Bs(x, t)
∂t
= Ds(x)∇2Bs(x, t) + rscellRad(Ω, t)− ηsBs(x, t) (10)
where Bs(x, t) denote the strength or concentration of the signal at position x and at time t,
Ds(x) is the diffusion coefficient of the signal (which is assumed to be constant), rs is the rate
at which the signal is produced by a irradiated cell, cellRad(Ω, t) (cellRad(Ω, t) = 1 if position
x ∈ Ω is occupied by a signal producing irradiated cell at time t and zero otherwise) and ηs is
the decay rate of the signal. The bystander cells will then respond to these signals in multiple
ways with various probabilities when the signal concentration is higher than certain assumed
threshold.
Parameter Estimation
Most of the parameters related to the cell-cycle model and oxygen dynamics are chosen from
previous mathematical and experimental papers. In the cell-cycle model, the parameter values
are chosen from Tyson and Novak’s papers [5, 6] but with time scales relevant to mammalian
5cell-cycle (Table 1). Here, we have assumed a cell-cycle time of 20-30 hrs under favourable
conditions for a normal cell. The rest of the parameter values of the cell-cycle model can be
found in Table 1.
Table 1. cell-cycle model parameters from [3,5, 6] (after rescaling to obtain a normal
cell-cycle time of 20-25 hrs)
Component Rate constants (hr−1) Dimensionless constants
[CycB] k1 = 0.24, k
′
2 = 0.24, k
′′
2 = 9, [p27/p21]=2.1 [CycB]th = 0.1
[Cdh1] k′3 = 6,k
′′
3 = 60, k4 = 210 J3 = 0.04,J4 = 0.04
[p55cdcT] k
′
5 = 0.03, k
′′
5 = 1.2, k6 = 0.6 J5 = 0.3, n = 4
[p55cdcA] k7 = 6,k8 = 3 J7 = 0.001,J8 = 0.001,[Mad]=1
[Plk1] k9 = 0.6, k10 = 0.12
The oxygen dynamics are governed by a reaction diffusion equation, where the parameters
are mainly chosen from the literature [11]. The oxygen diffusion length scale L is often consid-
ered to be approximately equal to 100 µm and the value of the diffusion constant is taken as
2∗10−5 cm2/s [12]. Using these and the relation L = √D/φ, the mean oxygen uptake can be ap-
proximately estimated as 0.2 s−1. The oxygen supply through the blood vessel is approximately
taken as 8.2 ∗ 10−3mols s−1 [13].
Figure S2. Sensitivity analysis of the probabilities that determine the production of
bystander signals. Figure shows the number of cells killed when tumour cells receive 0.25 Gy
and 2 Gy dosage and normal cells receive a decreasing dosage (case 1) for various combination
of probabilities
6Figure S3. Sensitivity analysis of the probabilities that determine the response of bystander
cells to bystander signals. Figure shows the number of cells killed when tumour cells receive
0.25 Gy and 2 Gy dosage and normal cells receive a decreasing dosage (case 1) for various
combination of probabilities
Figure S4. Sensitivity analysis of the thresholds above which bystander cells respond to
bystander signals. Figure shows the number of cells killed when tumour cells receive 0.25 Gy
and 2 Gy dosage and normal cells receive a decreasing dosage (case 1) for three different
threshold levels
7Sensitivity Analysis
In the present model, the dynamics of bystander signals and responses of bystander cells to
these signals are analysed based on probabilistic approach as it is hard to determine the exact
probabilities by which these bystander responses of normal or tumour cells occur [14]. To study
how these probabilities (signal production: Pns and Pts and bystander response: Pnb and Ptb
in Figure 2 of main manuscript) affect on the direct and indirect radiobiological responses and its
contributions to total cell-kill, a sensitivity analysis is carried out here by varying these proba-
bilities and comparing the total cell-kill. Figure S2 shows the total cell-kill and the contributions
from the direct and bystander cell-kills with respect to varying probabilities that determine the
total number of bystander signal producing cells. Figure S2.A shows the cell-kill when 60% of
the radiation exposed tumour cells and 50%, 35%, 20 % and 0% normal cells produce bystander
signals. Here, the probabilities are chosen in such a way that Pts > Pns as observed. The
bar plots indicate that the contribution from the direct cell-kill estimated using the modified
LQ model relatively same for all the combinations, while the bystander cell-kill increased with
an increase in the probability of signal producing normal cells (Pns), as expected. A similar
inference but with reduced bystander cell-kill can be deduced from the Figure S2.B where the
the probability for a irradiated tumour cells to produce bystander signal is 10% lower. The
effects of varying probabilities for a bystander tumour or normal cell to respond to the sur-
rounding bystander signals is plotted in Figure S3. The plots show that the minor variation in
the probabilities has no significant effects on the final cell-kill and as seen in the above case, the
direct cell-kill remains mostly the same. Please note that the responses of the bystander cells are
also affected by the concentration of the bystander signals and as one expect, a lower threshold
(Kn1, Kn2, Kt1 and Kt2) can increase the number of bystander cells that are susceptible for
bystander responses (as shown in Figure S4).
Direct and Bystander Effects
Case 1: Targeting normal and tumour cells with varying dosage
Figure S5.A shows the radiation-induced cell-kill and the number of cells under repair delay
for various doses per fraction. The plots show the radiation-induced cell-kill (both tumour and
normal) and the number of cells that undergo radiation or bystander signal induced repair delay
in their respective cell-cycle phases. We have assumed that the radiation can induce a cell-cycle
delay, forcing cells to stay in the same cell-cycle phase for an extra time duration of up to 9
hours [4]. Additionally, depending on the intensity and the probability, bystander signals may
also induce a cell-cycle delay of upto 6 hours [15]. The plots show an increased cell-kill when
the host-tumour system is irradiated with doses greater than 0.5 Gy and at low dose rates, more
normal cells are under radiation-induced repair delay. Figure S5.B shows the total number of
cells that survive the cell-kill due to direct irradiation but undergo cell-cycle delay to repair the
DNA damage and produce further radiation-induced bystander signals. At low doses there is
a higher number of signalling tumour cells and normal cells, whilst the number of signalling
tumour cells is lower at high doses due to increased cell-kill. In addition to these signalling
cells, the cells that undergo radiation-induced cell-death (but are still-alive) are also assumed
to produce bystander signals. We assume that the dead cells do not emit bystander signals.
8Figure S5. Plots showing the direct and indirect effects of radiation when tumour cells are
exposed to full given radiation dose while the surrounding normal cells receive gradient of
doses. (A) Plots show various direct effects of irradiation for multiple doses, (B) Plots show
the number of cells producing bystander signals, (C) Plots show number of cells with
bystander signal induced repair-delay and (D) Plots show the effects of bystander signals on
normal and tumour cells
The bystander responses to the radiation-induced bystander signals are given in Figures S5.C
and S5.D. As expected, the number of cells undergoing cell repair delay is higher for low doses
as more cells are exposed to the moderate intensity bystander signals. At high dose rates, the
increased cell-kill results in more localised sources of the diffusing bystander signal and although
the number of cells under repair-delay is low during radiation, more cells are being exposed to
moderate signal intensities after radiation.
Case 2: Targeting tumour cells
Figures S6.A and S6.B show the direct cell-kill as well as the total number of cells under repair
delay and the total number of signalling cells. As normal cells are spared from radiation exposure,
9Figure S6. Plots showing the direct and indirect effects of radiation when tumour cells are
exposed to full given radiation dose while the surrounding normal cells are spared completely.
(A) Plots show various direct effects of irradiation for multiple doses, (B) Plots show the
number of cells producing bystander signals, (C) Plots show number of cells with bystander
signal induced repair-delay and (D) Plots show the effects of bystander signals on normal and
tumour cells
none of the normal cells undergo radiation-induced cell-cycle delay and although the number
of tumour cells under delay is higher for low-dose radiation, it is significantly lower when high
doses per fraction are given. Consequently, in this scenario, only the tumour cells produce the
radiation-induced bystander signals and thus will have less effect on the surrounding normal
cells. The effects of radiation-induced bystander signals produced by irradiated tumour cells
are given in the Figures S6.C and S6.D. The plots show that while the bystander signals induce
cell-cycle delay and cell-kill within the tumour cells, they have no major effects on normal cells
as cells are assumed to respond to the bystander signals only when signal concentration is above
a threshold level. This is a therapeutic ideal - reducing the normal tissue damage while still
maintaining the tumour control, and may not be achievable using the current clinical delivery
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Figure S7. Plots showing the direct and indirect effects of radiation when tumour and
normal cells are exposed to full given radiation dose. (A) Plots show various direct effects of
irradiation for multiple doses, (B) Plots show the number of cells producing bystander signals,
(C) Plots show number of cells with bystander signal induced repair-delay and (D) Plots show
the effects of bystander signals on normal and tumour cells
methods.
Case 3: Targeting normal and tumour cells with full dose
Figure S7.A shows an increased cell-kill due to the direct effects and a similar distribution of
total cells that are under the repair delay. Figure S7.B shows that the number of signalling
normal cells is lower compared to case 1, since all the cells receive high dose and are more likely
to be killed directly. The bystander responses plotted in Figures S7.C and S7.D show that the
bystander responses are similar to that of case 1 at low doses whilst fewer cells responded to
the bystander signals at high doses due to a weaker bystander signals concentration. Here in
case 3, although the full dose delivery to the host-tumour system increases the overall cell-kill, it
comes in an expense of normal cell-kill and radiation damage, which should be avoided in ideal
11
scenario.
References
1. Andasari V, Roper RT, Swat MH, Chaplain MA. 2012. Integrating intracellular dynamics using
CompuCell3D and Bionetsolver: applications to multiscale modelling of cancer cell growth and
invasion. PLoS ONE. 7(3), e33726.
2. Powathil GG, Chaplain MAJ, Swat M. 2014. Investigating the development of chemotherapeutic
drug resistance in cancer: A multiscale computational study . IET Systems Biology (submitted).
2014.
3. Powathil GG, Gordon KE, Hill LA, Chaplain MA. 2012 May. Modelling the effects of cell-cycle
heterogeneity on the response of a solid tumour to chemotherapy: Biological insights from a hybrid
multiscale cellular automaton model. J Theor Biol. 308, 1–9.
4. Powathil GG, Adamson DJ, Chaplain MA. 2013 Jul. Towards predicting the response of a solid
tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational
model. PLoS Comput Biol. 9(7), e1003120.
5. Tyson JJ, Novak B. 2001 May. Regulation of the eukaryotic cell cycle: molecular antagonism,
hysteresis, and irreversible transitions. J Theor Biol. 210, 249–263.
6. Novak B, Tyson JJ. 2003 Dec. Modelling the controls of the eukaryotic cell cycle. Biochem Soc
Trans. 31, 1526–1529.
7. Powathil G, Kohandel M, Milosevic M, Sivaloganathan S. 2012. Modeling the spatial distribution of
chronic tumor hypoxia: implications for experimental and clinical studies. Comput Math Methods
Med. 2012, 410602.
8. Titz B, Jeraj R. 2008 Sep. An imaging-based tumour growth and treatment response model:
investigating the effect of tumour oxygenation on radiation therapy response. Phys Med Biol.
53(17), 4471–4488.
9. Pawlik TM, Keyomarsi K. 2004 Jul. Role of cell cycle in mediating sensitivity to radiotherapy. Int
J Radiat Oncol Biol Phys. 59(4), 928–942.
10. Maity A, McKenna WG, Muschel RJ. 1994 Apr. The molecular basis for cell cycle delays following
ionizing radiation: a review. Radiother Oncol. 31(1), 1–13.
11. Macklin P, Edgerton ME, Thompson AM, Cristini V. 2011. Patient-calibrated agent-based mod-
elling of ductal carcinoma in situ (DCIS): From microscopic measurements to macroscopic predic-
tions of clinical progression. J Theor Biol. (accepted pending revision).
12. Owen MR, Byrne HM, Lewis CE. 2004 Feb. Mathematical modelling of the use of macrophages as
vehicles for drug delivery to hypoxic tumour sites. J Theor Biol. 226, 377–391.
13. Matzavinos A, Kao CY, Green JE, Sutradhar A, Miller M, Friedman A. 2009 Jul. Modeling oxygen
transport in surgical tissue transfer. Proc Natl Acad Sci USA. 106, 12091–12096.
14. Mothersill C, Seymour C. 2006. Radiation-induced bystander effects: evidence for an adaptive
response to low dose exposures? Dose Response. 4(4), 283–290.
15. Hu B, Wu L, Han W, Zhang L, Chen S, Xu A, et al. 2006 Feb. The time and spatial effects of
bystander response in mammalian cells induced by low dose radiation. Carcinogenesis. 27(2),
245–251.
